IGF::OT::IGF NExT Project IDH1_2-Pyridinone TO#2 Characterization of Tox of Potential Anticancer Compounds Following Multiple Dose Admin to Rats, 1/26/17-6/30/18, Pre-clin Tox Study of Drug Dev for Ca

Battelle Memorial Institu, Columbus OH

Investigators

Abstract

The test agent is being considered for development as an anticancer therapeutic. The objective of this task was to characterize the target organ toxicities of an investigative agent that might move forward to clinical testing for anticancer activity. The information obtained from this investigation was used to identify drugs with the potential to treat cancer.